glp-1 and general anesthesia A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or Perioperative management of patients taking
Description
GLP-1R signaling in healthy aging Recent studies on GLP-1 have examined its possible influence on the aging process, alongside its established roles in regulating glucose metabolism and appetite
Microdosing is not an FDA-recognized term or a formally defined clinical protocol when it comes to GLP-1 medications
GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure
1), scientists have begun to explore GLP-1 therapeutics as possible treatments for substance use disorders
